首页> 外文期刊>Vaccine >HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX B/E.
【24h】

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX B/E.

机译:在ALVAC-HIV和AIDSVAX B / E的RV144初免疫苗组合的泰国族裔接受者中,HIV-1进化枝特异性中和抗体应答的HLA II类限制。

获取原文
获取原文并翻译 | 示例
           

摘要

Immune responses to vaccines may be influenced or associated with allelic variants of host genes such as those encoding human leucocyte antigens (HLA). We have molecularly determined the HLA class II DR and DQ gene, allele and haploype profiles in HIV-1 negative ethnic Thai recipients of an HIV-1 prime boost vaccine regimen, designed to induce neutralizing antibody (NAb) responses to HIV-1 CRF01_AE. Non-response to vaccine associated with DRB1*11 (3/32 responders vs. 7/13 non-responders, pc =0.027) and DRB1*16:02 (0/32 responders vs. 4/13 non-responders, pc =0.078) alleles. Furthermore, vaccine recipients with HLA-DQ heterodimers encoded by DQA1*05:01 and DQB1*03:01 alleles, were much less likely to produce NAb ( p=0.009). These data suggest that the lack of response to a vaccine designed to induce clade-specific NAb to HIV-1 is associated with the presence of certain HLA class II alleles and heterodimers in some Southeast Asians.
机译:对疫苗的免疫反应可能会影响宿主基因的等位基因变异或与之相关,例如编码人白细胞抗原(HLA)的那些。我们已经分子确定了HIV-1初免疫苗方案的HIV-1阴性泰国泰国接受者中的HLA II类DR和DQ基因,等位基因和半乳糖型谱,旨在诱导对HIV-1 CRF01_AE的中和抗体(NAb)反应。对与DRB1 * 11(3/32反应者vs.7 / 13无反应者,pc = 0.027)和DRB1 * 16:02(0/32反应者vs.4 / 13无反应者,pc = 0.078)等位基因。此外,具有由DQA1 * 05:01和DQB1 * 03:01等位基因编码的HLA-DQ异二聚体的疫苗接种者产生NAb的可能性要小得多(p = 0.009)。这些数据表明,在某些东南亚人中,针对旨在诱导进化枝特异性NAb的HIV-1疫苗缺乏反应与某些HLA II类等位基因和异二聚体的存在有关。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号